Clinical Trials Logo

Filter by:
NCT ID: NCT04684732 Enrolling by invitation - Atrial Fibrillation Clinical Trials

Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation Patients

Start date: December 14, 2020
Phase:
Study type: Observational

The purpose of this study is to assess pharmacokinetics and pharmacodynamics of Apixaban and clinical outcome of Apixaban in Thai patients with nonvalvular atrial fibrillation with varying degree of creatinine clearance

NCT ID: NCT05906563 Enrolling by invitation - Bone Loss in Jaw Clinical Trials

Evaluation of Melatonin and Metformin Loaded Nanoparticles in the Treatment of Periodontal Intra-bony Defects

Start date: December 14, 2022
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to assess the effectiveness of local delivery of melatonin and metformin loaded nanoparticle gel as adjunct to scaling and root planning (SRP) in the treatment of periodontal intra bony defect. fifty two healthy patients(n=52) with at least one periodontal intra-bony defect will be included in the study, all selected patients will be motivated about the benefit of plaque control and periodontal treatment . The participant will be selected from outpatient clinic of the Department of Oral Medicine and Periodontology , Faculty of dentistry, Mansoura University . The participant will be classified into four groups :group I and II are test groups but group III and IV are control groups .Patients in group I will be treated with melatonin loaded nanoparticle gel while in group II will be treated with melatonin and metformin loaded nanoparticles which will be applied weekly for four weeks after SRP had been completed and group III will be treated with placebo gel while group IV will be treated with only scaling and root planning.

NCT ID: NCT03635554 Enrolling by invitation - Aphasia Clinical Trials

Translation and Clinical Implementation of a Test of Language and Short-term Memory in Aphasia

ClinTALSA
Start date: December 15, 2017
Phase:
Study type: Observational

This project aims to develop a clinically feasible version of a laboratory-developed assessment battery for language and verbal short-term memory difficulties in aphasia.

NCT ID: NCT04098588 Enrolling by invitation - Treatment Refusal Clinical Trials

Behavioral Economics Intervention to Increase Treatment Seeking in the National Guard

BEAST
Start date: December 15, 2019
Phase: N/A
Study type: Interventional

The study is a randomized controlled trial of a single-session behavioral economics (research combining the areas of economics, social psychology, and cognitive psychology) intervention (i.e., BEAST) is a"warrior-culture" consistent (i.e., focusing on positive soldier traits, solving practical problems), highly scalable, and extremely brief (10-minute) intervention to encourage treatment seeking among MS National Guard problems for various life stressors. Participants will be 112 National Guard members. It is hypothesized that BEAST will lead to more self-reported motivation to seek treatment and more actual treatment seeking behavior.

NCT ID: NCT04129866 Enrolling by invitation - Suicidal Ideation Clinical Trials

Mobile Interpretation Bias Modification Clinical Trial

M-IBM
Start date: December 15, 2019
Phase: N/A
Study type: Interventional

The Mobile-Interpretation Bias Modification clinical trial aims to examine the efficacy of a brief mobile phone delivered interpretation bias modification to reduce anxiety sensitivity cognitive concerns and suicidal ideation in National Guard Personnel. The investigators propose a randomized controlled trial testing the efficacy, acceptability, and usability of M-IBM with a sample of 114 National Guardsmen with current suicidal ideation and elevated anxiety sensitivity cognitive concerns. Participants will complete assessments, receive assistance on installing M- IBM on their phone, complete an M-IBM intervention session, and complete post-intervention assessments. Baseline measures of psychopathology, and usability/acceptability of M-IBM will be obtained during the initial session. In addition, 1-month, and 3-month follow-ups would be scheduled to examine changes in psychopathology. The investigators hypothesize that those randomized to M-IBM will experience reductions in anxiety sensitivity cognitive concerns, suicidal ideation. In addition participants will find M-IBM acceptable and easy to use.

NCT ID: NCT04646915 Enrolling by invitation - Colorectal Cancer Clinical Trials

Evaluation of Short-term Outcomes of Day Surgery for Patients With CuRC

Start date: December 15, 2019
Phase:
Study type: Observational [Patient Registry]

To evaluate the feasibility and safety of laparoscopic colectomy and anterior resection for patients with colon/upper rectal cancer (CuRC) in day surgery center. Patients with colon or upper rectal cancer who meet the standards of day surgery will be enrolled, and laparoscopic radical resection of tumor will be performed in day surgery center. Perioperative outcomes of these patients and reasons for transferring to inpatient ward will be recorded prospectively.

NCT ID: NCT04066881 Enrolling by invitation - HIV Infections Clinical Trials

A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP

PrEPVacc
Start date: December 15, 2020
Phase: Phase 2
Study type: Interventional

This international, multi-centre, double-blind vaccine study is a three-arm prospective 1:1:1 randomisation comparing each of two experimental combination vaccine regimens i.e. DNA/AIDSVAX (weeks 0,4,24,48) and DNA/CN54gp140 (weeks 0,4) + MVA/CN54gp140 (weeks 24,48) with placebo control. There will be a concurrent open-label 1:1 randomisation to compare daily TAF/FTC (week 0-26) to daily TDF/FTC (weeks 0-26) as pre-exposure prophylaxis. The study aims to randomise up to 1668 eligible adults (18-40 years) through collaborating clinical research centres in 4 countries (Mozambique; South Africa; Tanzania; and Uganda). Each participant will be followed for a minimum of 74 weeks after enrolment. The trial is designed to detect a reduction in HIV incidence that has public health relevance sufficient to justify implementation of the combination vaccine regimen. In light of the high level of effectiveness demonstrated in the PrEP trials (up to 86% reduction in HIV), this trial is powered to detect a protective vaccine efficacy of 70% at the final analysis. The PrEP component will determine whether the effectiveness of TAF/FTC is unacceptably lower than the effectiveness of TDF/FTC.

NCT ID: NCT04665245 Enrolling by invitation - Covid19 Clinical Trials

Symptom-Based Markers for COVID-19 Transmission

Start date: December 15, 2020
Phase:
Study type: Observational

In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.

NCT ID: NCT04735211 Enrolling by invitation - Pediatric ALL Clinical Trials

Chronic Postsurgical Pediatric Pain. Evaluation Risk Factors to Develop Chronic Postsurgical Pain in Children and Adolescents Undergoing Surgery in a First Level Hospital

Start date: December 15, 2020
Phase:
Study type: Observational

Chronic postsurgical pain had number of prevalence on 20%. Its derivates from risk factors, but recent research provide new potential risk factors to develop chronic postsurgical pediatric pain. To increase the body of knowledge, an observational study is proposed in pediatric patients undergoing surgical intervention.

NCT ID: NCT04921605 Enrolling by invitation - Clinical trials for Tricuspid Regurgitation

Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

The study is designed to assess the feasibility of the DragonFly transcatheter mitral valve clamping system for the treatment of symptomatic severe tricuspid regurgitation.